SR-17018
Aliases: 5,6-dichloro desmethylchlorphine
Summary
Sold solely as a research chemical with no quality control or clinical data in humans. SR-17018 is not orally bioavailable when dissolved in water due to poor solubility; must be taken as powder or with appropriate excipients. Primarily reported for opioid tapering due to craving suppression and tolerance reduction properties, not recreation.
Dose Information
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset |
|---|---|---|---|---|
| Oral | 15-45 min | 30-60 min | 1-3 hrs | 4-6 hrs |
| Sublingual | 10-30 min | 20-45 min | 1-3 hrs | 4-6 hrs |
Effect Profile
Scores (1–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Weighted by importance: core (×3), major (×2), minor (×1)
Moderate euphoria and itching/nausea with mild pain relief, low sedation
Tolerance
Tolerance Decay
Model reflects preclinical evidence for relatively slower tolerance build than morphine in some assays and community reports of tolerance reduction during SRβ17018 use; human kinetics unknown. Values are heuristic for harmβreduction planning, not physiological truths.
Cross-Tolerances
Effects
- Pain relief
- Physical euphoria
- Stimulation
- Nausea
- Respiratory depression
- Pupil dilation
- Increased heart rate
- Teeth grinding
- Sedation
- Itchiness
- Cognitive euphoria
- Craving suppression
- Anxiety suppression
- Wakefulness
- Focus enhancement
- Motivation enhancement
- Constipation
- Dizziness
- Anxiety
- Cognitive fatigue
- Tactile enhancement
- Color enhancement
- Increased music appreciation
- Appetite suppression
- Light sensitivity
- Disinhibition
- Dulled perception
- Increased sexuality
- Visual and auditory hallucinations
- Drifting